Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

2.

Direct reconstruction and associated uncertainties of 192Ir source dwell positions in ring applicators using gafchromic film in the treatment planning of HDR brachytherapy cervix patients.

Awunor OA, Dixon B, Walker C.

Phys Med Biol. 2013 May 21;58(10):3207-25. doi: 10.1088/0031-9155/58/10/3207. Epub 2013 Apr 19.

PMID:
23603854
3.

Assessment of a source position checking tool for the quality assurance of transfer tubes used in HDR 192Ir brachytherapy treatments.

Awunor OA.

Brachytherapy. 2018 May - Jun;17(3):628-633. doi: 10.1016/j.brachy.2017.12.001. Epub 2018 Jan 17.

PMID:
29352643
4.

Spatial reproducibility of the ring and tandem high-dose rate cervix applicator.

Bahena JH, Martinez A, Yan D, Mele E, Edmunson G, Brown D, Hardy M, Brabbins D, Gustafson G.

Int J Radiat Oncol Biol Phys. 1998 Apr 1;41(1):13-9.

PMID:
9588912
5.

Surface dose characterisation of the Varian Ir-192 HDR conical surface applicator set with a vertically orientated source.

Buchauer K, Henke G, Schiefer H, Plasswilm L.

Strahlenther Onkol. 2014 Nov;190(12):1163-8. doi: 10.1007/s00066-014-0713-2. Epub 2014 Aug 1.

PMID:
25081332
6.

Commissioning of Varian ring & tandem HDR applicators: reproducibility and interobserver variability of dwell position offsets.

McMahon R, Zhuang T, Steffey BA, Song H, Craciunescu OI.

J Appl Clin Med Phys. 2011 Nov 15;12(4):3447. doi: 10.1120/jacmp.v12i4.3447.

7.

A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatment.

Palmer AL, Diez P, Gandon L, Wynn-Jones A, Bownes P, Lee C, Aird E, Bidmead M, Lowe G, Bradley D, Nisbet A.

Radiother Oncol. 2015 Feb;114(2):264-71. doi: 10.1016/j.radonc.2014.12.006. Epub 2015 Jan 9.

PMID:
25583568
8.

Improved source path localisation in ring applicators and the clinical impact for gynecological brachytherapy.

Humer I, Kirisits C, Berger D, Trnková P, Pötter R, Nesvacil N.

J Contemp Brachytherapy. 2015 Jun;7(3):239-43. doi: 10.5114/jcb.2015.52622. Epub 2015 Jun 29.

9.
10.

Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry.

Casey KE, Alvarez P, Kry SF, Howell RM, Lawyer A, Followill D.

Med Phys. 2013 Nov;40(11):112102. doi: 10.1118/1.4824915.

11.

A novel system for commissioning brachytherapy applicators: example of a ring applicator.

Fonseca GP, Van den Bosch MR, Voncken R, Podesta M, Verhaegen F.

Phys Med Biol. 2017 Oct 19;62(21):8360-8375. doi: 10.1088/1361-6560/aa8d0a.

PMID:
28914613
12.

Multihelix rotating shield brachytherapy for cervical cancer.

Dadkhah H, Kim Y, Wu X, Flynn RT.

Med Phys. 2015 Nov;42(11):6579-88. doi: 10.1118/1.4933244.

13.

The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.

Espinoza A, Beeksma B, Petasecca M, Fuduli I, Porumb C, Cutajar D, Corde S, Jackson M, Lerch ML, Rosenfeld AB.

Med Phys. 2013 Nov;40(11):111702. doi: 10.1118/1.4822736.

PMID:
24320410
14.

Dwell position inaccuracy in the Varian GammaMed HDR ring applicator.

Stern RL, Liu T.

J Appl Clin Med Phys. 2010 Sep 7;11(4):3158.

15.

A multicentre audit of HDR/PDR brachytherapy absolute dosimetry in association with the INTERLACE trial (NCT015662405).

Díez P, Aird EGA, Sander T, Gouldstone CA, Sharpe PHG, Lee CD, Lowe G, Thomas RAS, Simnor T, Bownes P, Bidmead M, Gandon L, Eaton D, Palmer AL.

Phys Med Biol. 2017 Nov 9;62(23):8832-8849. doi: 10.1088/1361-6560/aa91a9.

PMID:
28984277
16.

Determination of transit dose profile for a (192)Ir HDR source.

Fonseca GP, Rubo RA, Minamisawa RA, dos Santos GR, Antunes PC, Yoriyaz H.

Med Phys. 2013 May;40(5):051717. doi: 10.1118/1.4802731.

PMID:
23635265
17.

Optimization in high dose rate brachytherapy for utero-vaginal applications.

Cetingöz R, Ataman OU, Tuncel N, Sen M, Kinay M.

Radiother Oncol. 2001 Jan;58(1):31-6.

PMID:
11165679
19.

Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy.

Hellebust TP, Kirisits C, Berger D, Pérez-Calatayud J, De Brabandere M, De Leeuw A, Dumas I, Hudej R, Lowe G, Wills R, Tanderup K; Gynaecological (GYN) GEC-ESTRO Working Group.

Radiother Oncol. 2010 Aug;96(2):153-60. doi: 10.1016/j.radonc.2010.06.004.

PMID:
20663578
20.

Problems and uncertainties with multiple point A's during multiple high-dose-rate intracavitary brachytherapy in carcinoma of the cervix.

Datta NR, Basu R, Das KJ, Rajasekar D, Pandey CM, Singh U, Ayyagari S.

Clin Oncol (R Coll Radiol). 2004 Apr;16(2):129-37.

PMID:
15074737

Supplemental Content

Support Center